During the past decade, The first affiliated hospital of Nanjing Medical University conducted 249 clinical trials. In the 10-year time frame, 249 clinical trials started and 20 clinical trials were completed, i.e. on average, 8% percent of trials that started reached the finish line to date. In the past 5 years, 155 clinical trials started and 18 clinical trials were completed. i.e. 11.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The first affiliated hospital of Nanjing Medical University" #1 sponsor was "The First Affiliated Hospital with Nanjing Medical University" with 135 trials, followed by "Nanjing Medical University" with 29 trials sponsored, "Nanjing First Hospital, Nanjing Medical University" with 11 trials sponsored, "Celgene" with 9 trials sponsored and "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 9 trials sponsored. Other sponsors include 94 different institutions and companies that sponsored additional 77 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The first affiliated hospital of Nanjing Medical University" #1 collaborator was "The First Affiliated Hospital with Nanjing Medical University" with 13 trials as a collaborator, "National Natural Science Foundation of China" with 7 trials as a collaborator, "The First Hospital of Jilin University" with 6 trials as a collaborator, "Beijing Anzhen Hospital" with 5 trials as a collaborator and "Fudan University" with 5 trials as a collaborator. Other collaborators include 314 different institutions and companies that were collaborators in the rest 242 trials.

According to Clinical.Site data, the most researched conditions in "The first affiliated hospital of Nanjing Medical University" are "Atrial Fibrillation" (10 trials), "Coronary Artery Disease" (10 trials), "Breast Cancer" (7 trials), "Gastric Cancer" (7 trials) and "Heart Failure" (7 trials). Many other conditions were trialed in "The first affiliated hospital of Nanjing Medical University" in a lesser frequency.

Most popular intervention types in "The first affiliated hospital of Nanjing Medical University" are "Drug" (162 trials), "Procedure" (40 trials), "Device" (34 trials), "Other" (24 trials) and "Diagnostic Test" (11 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (22 trials), "Cyclophosphamide" (6 trials), "Rituximab" (6 trials), "Lenalidomide" (5 trials) and "placebo" (5 trials). Other intervention names were less common.

The vast majority of trials in "The first affiliated hospital of Nanjing Medical University" are 263 trials for "All" genders, 18 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are 129 active trials in "The first affiliated hospital of Nanjing Medical University". 13 are not yet recruiting, 98 are recruiting, 17 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 82 completed trials in The first affiliated hospital of Nanjing Medical University, 3 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in The first affiliated hospital of Nanjing Medical University, 30 "Phase 1" clinical trials were conducted, 43 "Phase 2" clinical trials and 39 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 35 trials, and there were also 87 trials that are defined as “Not Applicable".

The first affiliated hospital of Nanjing Medical University has several departments that took part in Clinical trials: "Department of Pharmacology, Institute of Clinical Pharmacology, Nanjing Medical University" - 2 trials